Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB056A | — |
Use of a Non-approved Diluent to Reconstitute and Administer the Lyophylized Meningococcal Group A Component of the 2-vial Presentation of Menveo; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB056A, expiry date 31-AUG-2025) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Use of a Non-approved Diluent to Reconstitute and Administer the Lyophylized Meningococcal Group A Component of the 2-vial Presentation of Menveo). The outcome of the wrong solution used in drug reconstitution was not applicable. Additional Information: GSK Receipt Date: 22-APR-2025 The nurse colleague administered a Menveo reconstituted with sterile water to a patient which led to wrong solution used in drug reconstitution. The vaccine administration facility was the same as primary reporter.